SD Biosensor

SD Biosensor Tangible Book Value per Share

The Tangible Book Value per Share of SD Biosensor (137310.KS) as of Nov 2, 2026 is 12,640.59 KRW. In the previous year, Tangible Book Value per Share was 6,783.20 KRW — a change of 86.35% (higher).

Tangible Book Value per Share

12,640.59KRW

YoY

86.35%

Last updated:

Tangible Book Value per Share of SD Biosensor is 2025 12,640.59 KRW. Tangible Book Value per Share of SD Biosensor was 2024 6,783.20 KRW. It decreases by 86.35% higher compared to the previous year.

The SD Biosensor Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2019
1,046.05 KRW
Jan 1, 2020
6,076.00 KRW
Jan 1, 2021
17,614.18 KRW
Jan 1, 2022
23,542.29 KRW
Jan 1, 2023
7,228.53 KRW
Jan 1, 2024
6,783.20 KRW
Jan 1, 2025
12,640.59 KRW
The SD Biosensor Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
12,640.59KRW+86.35%
6,783.20KRW-6.16%
7,228.53KRW-69.30%
23,542.29KRW+33.66%
17,614.18KRW+189.90%
6,076.00KRW+480.85%
1,046.05KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SD Biosensor stock

Tangible Book Value per Share of SD Biosensor is 12,640.59 KRW in 2025.

Tangible Book Value per Share of SD Biosensor changed from 6,783.20 KRW to 12,640.59 KRW, representing a 86.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SD Biosensor

All Key Metrics — SD Biosensor